Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Revenues
Net product revenues	$ 388,298	$ 326,647
License revenues	12,846,584	896,915
Total Revenues	13,234,882	1,223,562
Cost of revenues	117,035	198,750
Gross margin	13,117,847	1,024,812
Patent Monetization Expenses	8,216,749	1,687,802
Research and development expenses	767,680	487,858
General, administrative and selling expenses	1,446,205	1,162,782
Continuing operating income (loss)	2,687,213	(2,313,630)
Interest expense, net	(65,006)	(274)
Income (loss) from continuing operations before provision for income taxes	2,622,207	(2,313,904)
Provision for income taxes	154,513	214,136
Income (loss) from continuing operations	2,467,694	(2,528,040)
Income (loss) from discontinued operations	576,476	(364,553)
Net income (loss)	$ 3,044,170	$ (2,892,593)
Basic weighted average shares	64,000,309	63,721,035
Basic net income (loss) per share from continuing operations	$ 0.04	$ (0.04)
Basic net income (loss) per share from discontinuing operations	0.01	(0.01)
Basic net income (loss) per share	$ 0.05	$ (0.05)
Diluted weighted average shares	71,929,978	63,721,035
Diluted net income (loss) per share from continuing operations	$ 0.03	$ (0.04)
Diluted net income (loss) per share from discontinuing operations	0.01	(0.01)
Diluted net income (loss) per share	$ 0.04	$ (0.05)